Literature DB >> 19505697

Attitude towards adherence in patients with schizophrenia at discharge.

Rebecca Schennach-Wolff1, Markus Jäger, Florian Seemüller, Michael Obermeier, Thomas Messer, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz G Schmidt, Wolfgang Gaebel, Joachim Klosterkötter, Isabella Heuser, Wolfgang Maier, Matthias R Lemke, Eckart Rüther, Stefan Klingberg, Markus Gastpar, Hans-Jürgen Möller, Michael Riedel.   

Abstract

BACKGROUND: Purpose of the present study was to assess the attitude towards adherence at discharge and to verify its predictability using anamnestic and sociodemographic variables, factors influencing clinical treatment as well as the medical treatment applied.
METHODS: Attitude towards adherence was evaluated in 369 inpatients with schizophrenic spectrum disorders within a naturalistic multicenter trial using the Compliance Rating Scale (CRS) by Kemp. Biweekly ratings of the PANSS, UKU and the Subjective Well-being under Neuroleptic Treatment Scale (SWN-K) were applied. Logistic regression and CART analyses were used to determine significant predictor variables for the attitude towards adherence at discharge.
RESULTS: Sixty-seven percent of the patients were rated to have an attitude of active participation and moderate participation (=positive attitude towards adherence) and 33% of the patients to have an attitude of passive acceptance, occasional or permanent reluctance towards treatment as well as refusing treatment (=negative attitude towards adherence). A significant correlation was found between patients with a positive attitude towards adherence and course of all PANSS subscales. Statistical analyses revealed a reduction in PANSS general psychopathology subscore, employment status, greater illness insight and treatment with atypical antipsychotics to be significantly predictive for a positive attitude towards adherence at discharge.
CONCLUSIONS: The importance of an adequate antipsychotic treatment as a precondition for a favourable adherence attitude and the need to incorporate adherence-focused psychotherapy and psychoeducation into daily clinical practice are highlighted.

Entities:  

Mesh:

Year:  2009        PMID: 19505697     DOI: 10.1016/j.jpsychires.2009.05.003

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  11 in total

1.  Social interaction and drug attitude effectiveness in patients with schizophrenia.

Authors:  Jui-Kang Tsai; Wen-Kuo Lin; For-Wey Lung
Journal:  Psychiatr Q       Date:  2011-12

Review 2.  Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.

Authors:  Hendrik Müller; Sonja Laier; Andreas Bechdolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

3.  Antipsychotic agents: efficacy and safety in schizophrenia.

Authors:  Arão Nogueira de Araújo; Eduardo Pondé de Sena; Irismar Reis de Oliveira; Mario F Juruena
Journal:  Drug Healthc Patient Saf       Date:  2012-11-29

4.  Patient perspectives on antipsychotic treatments and their association with clinical outcomes.

Authors:  Hong Liu-Seifert; Olawale O Osuntokun; Jenna L Godfrey; Peter D Feldman
Journal:  Patient Prefer Adherence       Date:  2010-10-05       Impact factor: 2.711

5.  [Risk factors for treatment adherence in patients with schizophrenia: case-control study].

Authors:  Chadya Aarab; Fatima Elghazouani; Rachid Aalouane; Ismail Rammouz
Journal:  Pan Afr Med J       Date:  2015-03-20

6.  Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone.

Authors:  Franck Jean Baylé; Arnaud Tessier; Sophie Bouju; David Misdrahi
Journal:  Patient Prefer Adherence       Date:  2015-09-16       Impact factor: 2.711

7.  The Promises and Challenges of Ecological Momentary Assessment in Schizophrenia: Development of an Initial Experimental Protocol.

Authors:  Brandon A Gaudiano; Ethan Moitra; Stacy Ellenberg; Michael F Armey
Journal:  Healthcare (Basel)       Date:  2015-07-15

8.  Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder.

Authors:  Esteban Medina; Joan Salvà; Rubén Ampudia; Jorge Maurino; Juan Larumbe
Journal:  Patient Prefer Adherence       Date:  2012-08-29       Impact factor: 2.711

9.  Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.

Authors:  George Awad; Mariam Hassan; Antony Loebel; Jay Hsu; Andrei Pikalov; Krithika Rajagopalan
Journal:  BMC Psychiatry       Date:  2014-02-23       Impact factor: 3.630

10.  Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications.

Authors:  M S Karthik; Nisha Warikoo; Subho Chakrabarti; Sandeep Grover; Parmanand Kulhara
Journal:  Indian J Psychol Med       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.